The Chemours Company
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Material agreementSep 10 →InsidersNo open-market buys or sales.→HoldersBlackRock 15.5%Vanguard Portfolio 7.0%Vanguard 4.5%→PeersClosest companies: HUN, WLK, FCX→
From the filings
Figures
- Revenue
- $5.80Blast 12 months
- Net income
- −$304.0Mlast 12 months
- Operating cash flow
- $332.0Mlast 12 months
- Cash and equivalents
- $671.0Mat the last balance sheet
- Total debt
- $3.87Bat the last balance sheet
- Shares outstanding
- 150.5M shareson issue